发布求助
文献互助 智能选刊 最新文献

Nature Reviews Rheumatology最新文献

筛选
英文 中文
Opportunities and limitations of B cell depletion approaches in SLE 系统性红斑狼疮 B 细胞清除疗法的机遇与局限性
IF 33.7 1区 医学
Nature Reviews Rheumatology Pub Date : 2025-01-15 DOI: 10.1038/s41584-024-01210-9
Marit Stockfelt, Y. K. Onno Teng, Edward M. Vital
{"title":"Opportunities and limitations of B cell depletion approaches in SLE","authors":"Marit Stockfelt, Y. K. Onno Teng, Edward M. Vital","doi":"10.1038/s41584-024-01210-9","DOIUrl":"https://doi.org/10.1038/s41584-024-01210-9","url":null,"abstract":"<p>B cell depletion with rituximab, a chimeric monoclonal antibody that selectively targets B cells by binding CD20, has been used off label in severe and resistant systemic lupus erythematosus (SLE) for over two decades. Several biological mechanisms limit the efficacy of rituximab, including immunological reactions towards the chimeric molecule, increased numbers of residual B cells, including plasmablasts and plasma cells, and a post-treatment surge in B cell-activating factor (BAFF) levels. Consequently, rituximab induces remission in only a proportion of patients, and safety issues limit its use. However, the use of rituximab has established the value of B cell depletion strategies in SLE and has guided the development of several improved B cell depletion therapies for SLE. These include enhanced monoclonal antibodies, modalities that redirect the specificity of patient T cells using chimeric antigen receptor T cells or bispecific T cell engagers, and combination treatment that simultaneously inhibits the BAFF pathway. In this Review, we consider evidence gathered from over two decades of using rituximab in SLE and examine how B cell depletion therapies could be further optimized to achieve immunological and clinical efficacy. In addition, we discuss the prospects of B cell depletion strategies for personalized treatment in SLE based on genetic research and studies in pre-symptomatic individuals.</p>","PeriodicalId":18810,"journal":{"name":"Nature Reviews Rheumatology","volume":"27 1","pages":""},"PeriodicalIF":33.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142981504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Piezo1 as a therapeutic target for glucocorticoid-induced osteoporosis
IF 33.7 1区 医学
Nature Reviews Rheumatology Pub Date : 2025-01-10 DOI: 10.1038/s41584-024-01215-4
Holly Webster
{"title":"Piezo1 as a therapeutic target for glucocorticoid-induced osteoporosis","authors":"Holly Webster","doi":"10.1038/s41584-024-01215-4","DOIUrl":"https://doi.org/10.1038/s41584-024-01215-4","url":null,"abstract":"A study implicates the Hes1–Piezo1 signalling pathway in osteocytes in the pathogenesis of glucocorticoid-induced osteoporosis and demonstrates the beneficial effects of Yoda1, a Piezo1 agonist.","PeriodicalId":18810,"journal":{"name":"Nature Reviews Rheumatology","volume":"20 1","pages":""},"PeriodicalIF":33.7,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142939529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breaking research silos to achieve equitable precision medicine in rheumatology
IF 33.7 1区 医学
Nature Reviews Rheumatology Pub Date : 2025-01-10 DOI: 10.1038/s41584-024-01204-7
Hannah C. Ainsworth, DeAnna Baker Frost, S. Sam Lim, Paula S. Ramos
{"title":"Breaking research silos to achieve equitable precision medicine in rheumatology","authors":"Hannah C. Ainsworth, DeAnna Baker Frost, S. Sam Lim, Paula S. Ramos","doi":"10.1038/s41584-024-01204-7","DOIUrl":"https://doi.org/10.1038/s41584-024-01204-7","url":null,"abstract":"<p>Health disparities in rheumatic disease are well established and urgently need addressing. Obstacles to precision medicine equity span both the clinical and the research domains, with a focus placed on structural barriers limiting equitable health care access and inclusivity in research. Less articulated factors include the use of inaccurate population descriptors and the existence of research silos in rheumatology research, which creates a knowledge gap that precludes addressing the health disparities and fulfilling the goals of precision medicine to understand the ‘full patient’. The biopsychosocial model is a research framework that intertwines layers of biological and environmental effects to understand disease. However, very limited rheumatology research bridges across molecular and epidemiological studies of environmental exposures, such as physical and social determinants of health. In this Review, we discuss clinical obstacles to health care equity, including access to health care and the use of inaccurate language when labelling population groups. We explore the goals and data needed for research under the biopsychosocial model. We describe results from a rheumatic disease literature search that highlights the paucity of studies investigating the molecular influences of systemic exposures. We conclude with a list of considerations and recommendations to help achieve equitable precision medicine.</p>","PeriodicalId":18810,"journal":{"name":"Nature Reviews Rheumatology","volume":"50 1","pages":""},"PeriodicalIF":33.7,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142939507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in the calculation of minimal important change estimates for patient-reported outcome measures
IF 33.7 1区 医学
Nature Reviews Rheumatology Pub Date : 2025-01-02 DOI: 10.1038/s41584-024-01214-5
Ewa M. Roos
{"title":"Advances in the calculation of minimal important change estimates for patient-reported outcome measures","authors":"Ewa M. Roos","doi":"10.1038/s41584-024-01214-5","DOIUrl":"https://doi.org/10.1038/s41584-024-01214-5","url":null,"abstract":"In 2024, studies using more advanced methods to calculate the minimal important change have described how different methods and timings of estimating minimal important changes can affect the estimates.","PeriodicalId":18810,"journal":{"name":"Nature Reviews Rheumatology","volume":"34 1","pages":""},"PeriodicalIF":33.7,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142911486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precision weight management in people with knee osteoarthritis and overweight or obesity
IF 33.7 1区 医学
Nature Reviews Rheumatology Pub Date : 2024-12-23 DOI: 10.1038/s41584-024-01209-2
Shiwen Yuan, David J. Hunter
{"title":"Precision weight management in people with knee osteoarthritis and overweight or obesity","authors":"Shiwen Yuan, David J. Hunter","doi":"10.1038/s41584-024-01209-2","DOIUrl":"https://doi.org/10.1038/s41584-024-01209-2","url":null,"abstract":"Results of the STEP 9 trial show that semaglutide leads to improvements in knee osteoarthritis-related symptoms. The findings support weight-management pharmacotherapies as a feasible option for management of knee osteoarthritis, but cost-effectiveness, risk of toxicity and likelihood of rebound must be considered.","PeriodicalId":18810,"journal":{"name":"Nature Reviews Rheumatology","volume":"24 1","pages":""},"PeriodicalIF":33.7,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142874052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synovial dendritic cell subsets in RA
IF 33.7 1区 医学
Nature Reviews Rheumatology Pub Date : 2024-12-20 DOI: 10.1038/s41584-024-01213-6
Maria Papatriantafyllou
{"title":"Synovial dendritic cell subsets in RA","authors":"Maria Papatriantafyllou","doi":"10.1038/s41584-024-01213-6","DOIUrl":"https://doi.org/10.1038/s41584-024-01213-6","url":null,"abstract":"Synovial dendritic cell profiles and localization patterns provide insights about the roles of dendritic cell subsets in the initiation, remission and relapse of rheumatoid arthritis.","PeriodicalId":18810,"journal":{"name":"Nature Reviews Rheumatology","volume":"40 1","pages":""},"PeriodicalIF":33.7,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142866964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blocking CDK7 attenuates inflammatory arthritis
IF 33.7 1区 医学
Nature Reviews Rheumatology Pub Date : 2024-12-20 DOI: 10.1038/s41584-024-01211-8
Sarah Onuora
{"title":"Blocking CDK7 attenuates inflammatory arthritis","authors":"Sarah Onuora","doi":"10.1038/s41584-024-01211-8","DOIUrl":"https://doi.org/10.1038/s41584-024-01211-8","url":null,"abstract":"In a new study, inhibition of CDK7 disrupted the RNA polymerase II transcription cycle, leading to anti-inflammatory effects and metabolic reprogramming in macrophages and attenuation of arthritis in mouse models.","PeriodicalId":18810,"journal":{"name":"Nature Reviews Rheumatology","volume":"14 1","pages":""},"PeriodicalIF":33.7,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142866965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
European expert recommendations for managing systemic sclerosis and its complications
IF 33.7 1区 医学
Nature Reviews Rheumatology Pub Date : 2024-12-20 DOI: 10.1038/s41584-024-01205-6
Robyn T. Domsic
{"title":"European expert recommendations for managing systemic sclerosis and its complications","authors":"Robyn T. Domsic","doi":"10.1038/s41584-024-01205-6","DOIUrl":"https://doi.org/10.1038/s41584-024-01205-6","url":null,"abstract":"The updated 2023 EULAR recommendations for treatment of systemic sclerosis bring notable changes to recommendations for skin, peripheral vascular disease, interstitial lung disease and pulmonary arterial hypertension therapies, based on newer evidence. These updates provide the first glimmer of personalized patient management.","PeriodicalId":18810,"journal":{"name":"Nature Reviews Rheumatology","volume":"30 1","pages":""},"PeriodicalIF":33.7,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142866966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular profiling for advancing precision rheumatology
IF 33.7 1区 医学
Nature Reviews Rheumatology Pub Date : 2024-12-20 DOI: 10.1038/s41584-024-01208-3
Coziana Ciurtin, Elizabeth C. Jury
{"title":"Molecular profiling for advancing precision rheumatology","authors":"Coziana Ciurtin, Elizabeth C. Jury","doi":"10.1038/s41584-024-01208-3","DOIUrl":"https://doi.org/10.1038/s41584-024-01208-3","url":null,"abstract":"Here, we highlight three publications in 2024 that have advanced the field of molecular and immunological profiling, for&nbsp;the diagnosis, prognosis and treatment of patients with systemic autoimmune rheumatic diseases.","PeriodicalId":18810,"journal":{"name":"Nature Reviews Rheumatology","volume":"32 1","pages":""},"PeriodicalIF":33.7,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142866967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abatacept for myositis
IF 33.7 1区 医学
Nature Reviews Rheumatology Pub Date : 2024-12-20 DOI: 10.1038/s41584-024-01212-7
Sarah Onuora
{"title":"Abatacept for myositis","authors":"Sarah Onuora","doi":"10.1038/s41584-024-01212-7","DOIUrl":"https://doi.org/10.1038/s41584-024-01212-7","url":null,"abstract":"In a phase III clinical trial of abatacept for idiopathic inflammatory myopathy, the primary endpoint was not met but the results suggest abatacept could have benefits in some subtypes of the disease.","PeriodicalId":18810,"journal":{"name":"Nature Reviews Rheumatology","volume":"25 1","pages":""},"PeriodicalIF":33.7,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142867113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信